164 related articles for article (PubMed ID: 34579512)
1. Serum chitotriosidase and YKL-40 in acute pancreatitis: Reliability as prognostic marker for disease severity and correlation with inflammatory markers.
Ünal Çetin E; Kamiş F; Çetin AU; Beyazit Y; Kekilli M
Turk J Med Sci; 2021 Dec; 51(6):3038-3046. PubMed ID: 34579512
[TBL] [Abstract][Full Text] [Related]
2. Increased YKL-40 and Chitotriosidase in Asthma and Chronic Obstructive Pulmonary Disease.
James AJ; Reinius LE; Verhoek M; Gomes A; Kupczyk M; Hammar U; Ono J; Ohta S; Izuhara K; Bel E; Kere J; Söderhäll C; Dahlén B; Boot RG; Dahlén SE;
Am J Respir Crit Care Med; 2016 Jan; 193(2):131-42. PubMed ID: 26372680
[TBL] [Abstract][Full Text] [Related]
3. Serum YKL-40 levels and chitotriosidase activity as potential biomarkers in primary prostate cancer and benign prostatic hyperplasia.
Kucur M; Isman FK; Balci C; Onal B; Hacibekiroglu M; Ozkan F; Ozkan A
Urol Oncol; 2008; 26(1):47-52. PubMed ID: 18190830
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of chitotriosidase and YKL-40 in peripheral blood and sputum of healthy smokers and patients with chronic obstructive pulmonary disease.
Majewski S; Tworek D; Szewczyk K; Kiszałkiewicz J; Kurmanowska Z; Brzeziańska-Lasota E; Jerczyńska H; Antczak A; Piotrowski WJ; Górski P
Int J Chron Obstruct Pulmon Dis; 2019; 14():1611-1631. PubMed ID: 31413557
[TBL] [Abstract][Full Text] [Related]
5. Serum YKL-40 levels and chitotriosidase activity in patients with beta-thalassemia major.
Musumeci M; Caruso V; Medulla E; Torrisi V; Migale R; Angeletti S; Musumeci S
Dis Markers; 2014; 2014():965971. PubMed ID: 24808626
[TBL] [Abstract][Full Text] [Related]
6. High serum YKL-40 level positively correlates with coronary artery disease.
Jin Y; Cao JN; Wang CX; Feng QT; Ye XH; Xu X; Yang CJ
Biomark Med; 2017 Feb; 11(2):133-139. PubMed ID: 28097894
[TBL] [Abstract][Full Text] [Related]
7. Aberrant progranulin, YKL-40, cathepsin D and cathepsin S in Gaucher disease.
Afinogenova Y; Ruan J; Yang R; Kleytman N; Pastores G; Lischuk A; Mistry PK
Mol Genet Metab; 2019; 128(1-2):62-67. PubMed ID: 31358474
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal and Comparative Measures of Serum Chitotriosidase and YKL-40 in Patients With Idiopathic Pulmonary Fibrosis.
Majewski S; Szewczyk K; Jerczyńska H; Miłkowska-Dymanowska J; Białas AJ; Gwadera Ł; Piotrowski WJ
Front Immunol; 2022; 13():760776. PubMed ID: 35222369
[TBL] [Abstract][Full Text] [Related]
9. Serum YKL-40 as a potential biomarker of inflammation in psoriasis.
Baran A; Myśliwiec H; Szterling-Jaworowska M; Kiluk P; Świderska M; Flisiak I
J Dermatolog Treat; 2018 Feb; 29(1):19-23. PubMed ID: 28498006
[TBL] [Abstract][Full Text] [Related]
10. Elevated serum YKL-40 levels in patients with Kawasaki disease.
Kim KY; Ahn Y; Kim DY; Kim HS; Kim DS
Biomarkers; 2017; 22(3-4):326-330. PubMed ID: 27881022
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal Fluid YKL-40 and Chitotriosidase Levels in Frontotemporal Dementia Vary by Clinical, Genetic and Pathological Subtype.
Woollacott IOC; Nicholas JM; Heller C; Foiani MS; Moore KM; Russell LL; Paterson RW; Keshavan A; Schott JM; Warren JD; Heslegrave A; Zetterberg H; Rohrer JD
Dement Geriatr Cogn Disord; 2020; 49(1):56-76. PubMed ID: 32344399
[TBL] [Abstract][Full Text] [Related]
12. YKL-40 (Chitinase-3-Like Protein 1) Serum Levels in Aortic Stenosis.
Arain F; Abraityte A; Bogdanova M; Solberg OG; Michelsen AE; Lekva T; Aakhus S; Holm S; Halvorsen B; Finsen AV; Vinge LE; Nymo S; Espeland T; Ranheim T; Aukrust P; Vaage IJ; Auensen A; Gullestad L; Ueland T
Circ Heart Fail; 2020 Oct; 13(10):e006643. PubMed ID: 32962417
[TBL] [Abstract][Full Text] [Related]
13. YKL-40 as marker of severe lung disease in cystic fibrosis patients.
Leonardi S; Parisi GF; Capizzi A; Manti S; Cuppari C; Scuderi MG; Rotolo N; Lanzafame A; Musumeci M; Salpietro C
J Cyst Fibros; 2016 Sep; 15(5):583-6. PubMed ID: 26778616
[TBL] [Abstract][Full Text] [Related]
14. Chitotriosidase and YKL-40 in normal and pre-eclamptic pregnancies.
Madazli R; Kucur M; Gezer A; Isman F; Bulut B
Int J Gynaecol Obstet; 2008 Mar; 100(3):239-43. PubMed ID: 18054022
[TBL] [Abstract][Full Text] [Related]
15. YKL-40 levels increase with declining ankle-brachial index and are associated with long-term cardiovascular mortality in peripheral arterial disease patients.
Höbaus C; Tscharre M; Herz CT; Pesau G; Wrba T; Koppensteiner R; Schernthaner GH
Atherosclerosis; 2018 Jul; 274():152-156. PubMed ID: 29783062
[TBL] [Abstract][Full Text] [Related]
16. YKL-40, CCL18 and SP-D predict mortality in patients hospitalized with community-acquired pneumonia.
Spoorenberg SM; Vestjens SM; Rijkers GT; Meek B; van Moorsel CH; Grutters JC; Bos WJ;
Respirology; 2017 Apr; 22(3):542-550. PubMed ID: 27782361
[TBL] [Abstract][Full Text] [Related]
17. Clinical Utility of YKL-40 in Polymyositis/dermatomyositis-associated Interstitial Lung Disease.
Hozumi H; Fujisawa T; Enomoto N; Nakashima R; Enomoto Y; Suzuki Y; Kono M; Karayama M; Furuhashi K; Murakami A; Inui N; Nakamura Y; Mimori T; Suda T
J Rheumatol; 2017 Sep; 44(9):1394-1401. PubMed ID: 28711881
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic Cancer.
Schultz NA; Christensen IJ; Werner J; Giese N; Jensen BV; Larsen O; Bjerregaard JK; Pfeiffer P; Calatayud D; Nielsen SE; Yilmaz MK; Holländer NH; Wøjdemann M; Bojesen SE; Nielsen KR; Johansen JS
PLoS One; 2013; 8(6):e67059. PubMed ID: 23840582
[TBL] [Abstract][Full Text] [Related]
19. Increased serum YKL-40 level is associated with the presence and severity of metabolic syndrome.
Akboğa MK; Yalçın R; Şahinarslan A; Yılmaz Demirtaş C; Paşaoğlu H; Abacı A
Anatol J Cardiol; 2016 Dec; 16(12):953-958. PubMed ID: 27443476
[TBL] [Abstract][Full Text] [Related]
20. YKL-40 levels are associated with disease severity and prognosis of viral pneumonia, but not available in bacterial pneumonia in children.
Yang X; Sheng G
BMC Pediatr; 2018 Dec; 18(1):381. PubMed ID: 30514252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
